You are here

Development of a Low Profile Dual Hormone Patch Pump with Novel Occlusion Sensor

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43DK110972-01
Agency Tracking Number: R43DK110972
Amount: $255,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIDDK
Solicitation Number: DK15-022
Timeline
Solicitation Year: 2015
Award Year: 2016
Award Start Date (Proposal Award Date): 2016-09-01
Award End Date (Contract End Date): 2018-08-31
Small Business Information
534 W RESEARCH CENTER BLVD STE 260
Fayetteville, AR 72701-6534
United States
DUNS: 125518428
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 FORREST PAYNE
 (479) 527-6810
 forrest.payne@sfc-fluidics.com
Business Contact
 MARK KIDD
Phone: (479) 571-2592
Email: mark.kidd@sfc-fluidics.com
Research Institution
N/A
Abstract

Development of a Low Profile Dual Hormone Patch Pump
with Novel Occlusion Sensor
Project Summary
The Specific Aim of this project is to develop a discrete low profile dual hormone drug
delivery system using SFC Fluidics enabling microfluidic technologies A dual ePump will be
developed in which a single ePump body will independently and accurately deliver both insulin
and glucagon from two separate reservoirs Latching micro valve sets will independently and
safely control the delivery of each hormone and a flow confirmation sensor will identify dosing
errors from either occlusions or electrical mechanical failures Phase I will see the development
of an early prototype with control system and a dosing accuracy of for nL to L dosing
volumes will be targeted During Phase II SFC Fluidics will work closely with clinicians and
drug formulation glucose sensor and control algorithm developers to develop a robust and
reliable artificial pancreas Project Narrative
The proposed dual drug delivery system will have the necessary safety features and low
dose accuracy to meet the need for insulin and glucagon dual hormone delivery to type
diabetics including children and adolescents to greatly improve the quality of life for this
significant and growing at risk group

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government